Obesity with type 2 diabetes
Conditions
Interventions
None listed
Sponsors
Oita University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Obese diabetic patients 3 years or more after sleeve gastrectomy (SG), Roux-en-Y gastric bypass (RYGB), resectional RYGB, mini-gastric bypass (one anastomosis gastric bypass), and SG with duodenojejunal bypass (SG-DJB) as the primary operation
Exclusion criteria
Exclusion criteria: Patients who are not diagnosed as T2DM before operation Patients who have no data of preoperative C-peptide Patients who experienced severe complications such as leakage just after the first operation Patients who received revision surgery within 3 years after the first operation Patients who received pregnancy within 3 years after the first operation Patients who have lack of 3 years data (between 3-4 years) Patients who received other operations than SG, RYGB, resectional RYGB, mini-gastric bypass, and SG-DJB Patients who received open metabolic surgery (not laparoscopic) When patients experienced revision surgery or pregnancy between 4-5 years, 5 years data are only excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Which scoring system is better in prediction of T2DM remission in East Asian obese patients 3 and 5 years after metabolic surgery? | — |
Secondary
| Measure | Time frame |
|---|---|
| Who were good candidates for sleeve gastrectomy in East Asian countries? What is the better borderline point between mild and moderate stages in IMS score in East Asian countries? | — |
Countries
Japan,Asia(except Japan)
Contacts
Public ContactMasayuki Ohta
Oita University Global Oita Medical Advanced Research Center for Health
Outcome results
None listed